Projects per year
Personal profile
Biography
Nayyereh is an accomplished pharmacist and pharmacoeconomist, leveraging her educational background to drive impactful research and contribute to the field of healthcare. With a proven track record in conducting health technology assessments and health policy research, she is dedicated to improving patients' access to efficient treatment strategies.
Currently serving as a research fellow at the Centre for Health Economics at the Monash Business School, Nayyereh continues to explore innovative approaches to enhance healthcare outcomes and advance evidence-based decision-making in the field.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Pharmacoeconomics and Pharmaceutical Administration, PhD, Tehran University of Medical Sciences
21 Jan 2016 → 15 Jan 2022
Pharmacy, Pharmaceutical Doctorate (PharmD), Mashhad University of Medical Sciences
23 Sept 2009 → 15 Jan 2016
External positions
Visiting Researcher, Peter MacCallum Cancer Centre
Oct 2022 → Dec 2022
Health Economics & Outcome Research Advisor, Cobel Group
Aug 2018 → May 2023
Assistant University Lecturer, Ardabil University of Medical Sciences
Oct 2017 → Jan 2021
Assistant University Lecturer, Tehran University of Medical Sciences
Oct 2017 → Jan 2021
Business Development Specialist, Pars Darou Pharmaceutical Company
Sept 2017 → Sept 2018
Internship, Iran Food and Drug Administration
Apr 2016 → Apr 2017
Responsible Pharmacist, Tehran University of Medical Sciences
Jan 2013 → Jan 2018
Research area keywords
- Health Technology Assessments
- Economics of pharmaceuticals
- Economics of Health
- Decision Analytic Modelling
- Policy and Administration - Health Policy
- Pharmacogenomics
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Monitoring system for final trial overall survival (OS) results for cancer medicines
Li, J. J. (Primary Chief Investigator (PCI)), Sia, K. L. (Chief Investigator (CI)), Ghijben, P. (Chief Investigator (CI)), Petrie, D. (Chief Investigator (CI)), Picton, L. (Chief Investigator (CI)), Yong, K. (Chief Investigator (CI)), Chen, E. (Chief Investigator (CI)) & Ayati, N. (Chief Investigator (CI))
24/06/24 → 30/04/25
Project: Research
-
Production and regulatory issues for theranostics
Giammarile, F., Paez, D., Zimmermann, R., Cutler, C. S., Jalilian, A., Korde, A., Knoll, P., Ayati, N., Lewis, J. S., Lapi, S. E., Delgado Bolton, R. C., Kunikowska, J., Estrada Lobato, E., Urbain, J.-L., Holmberg, O., Abdel-Wahab, M. & Scott, A. M., Jun 2024, In: The Lancet Oncology. 25, 6, p. e260-e269 10 p.Research output: Contribution to journal › Review Article › Other › peer-review
13 Citations (Scopus) -
Radiotherapy and theranostics: a Lancet Oncology Commission
Abdel-Wahab, M., Giammarile, F., Carrara, M., Paez, D., Hricak, H., Ayati, N., Li, J. J., Mueller, M., Aggarwal, A., Al-Ibraheem, A., Alkhatib, S., Atun, R., Bello, A., Berger, D., Delgado Bolton, R. C., Buatti, J. M., Burt, G., Bjelac, O. C., Cordero-Mendez, L. & Dosanjh, M. & 32 others, , Nov 2024, In: The Lancet Oncology. 25, 11, p. e545-e580 36 p.Research output: Contribution to journal › Review Article › Research › peer-review
40 Citations (Scopus) -
Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics
Scott, A. M., Zeglis, B. M., Lapi, S. E., Scott, P. J. H., Windhorst, A. D., Abdel-Wahab, M., Giammarile, F., Piaez, D., Jalilian, A., Knoll, P., Korde, A., Vichare, S., Ayati, N., Lee, S. T., Lyashchenko, S. K., Zhang, J., Urbain, J. L. & Lewis, J. S., Jun 2024, In: The Lancet Oncology. 25, 6, p. e250-e259 10 p.Research output: Contribution to journal › Review Article › Other › peer-review
14 Citations (Scopus) -
Cost-effectiveness comparison between Ticagrelor and Clopidogrel in acute coronary syndrome in Iran
Hashemi-Meshkini, A., Tajik, A., Ayati, N., Nikfar, S., Koochak, R., Yaghoubifard, S., Abbasi, A. & Varmaghani, M., 2023, In: Journal of Tehran University Heart Center. 18, 2, p. 94-101 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile6 Citations (Scopus) -
Economic analysis of 177Lu-PSMA-I&T in Australian patients with metastatic castration-resistant prostate cancer
Ayati, N., Nov 2023, In: Internal Medicine Journal. 53, S4, 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access